Biology of Blood and Marrow Transplantation
Volume 11, Issue 8 , Pages 593-599 , August 2005

Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy-Refractory Non-Hodgkin Lymphoma

  • Robert M. Dean

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Daniel H. Fowler

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Wyndham H. Wilson

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Jeanne Odom

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Seth M. Steinberg

      Affiliations

    • Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Catherine Chow

      Affiliations

    • Diagnostic Radiology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland
    • ,
  • Claude Kasten-Sportes

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Ronald E. Gress

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • ,
  • Michael R. Bishop

      Affiliations

    • Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    • Corresponding Author InformationCorrespondence and reprint requests: Michael R. Bishop, MD, Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, CRC 3-3330, MSC 1203, Bethesda, MD 20892-1203

Received 26 January 2005 ,Accepted 25 April 2005.

  • Image Result

    Overall survival after RIST according to response to EPOCH-F. Responses to EPOCH-F were categorized as complete or partial response (CR/PR), stable disease (SD), or progressive disease (PD).

    Overall survival after RIST according to response to EPOCH-F. Responses to EPOCH-F were categorized as complete or partial response (CR/PR), stable disease (SD), or progressive disease (PD).

  • Image Result

    Event-free survival after RIST. SD indicates stable disease.

    Event-free survival after RIST. SD indicates stable disease.

PII: S1083-8791(05)00261-2

doi: 10.1016/j.bbmt.2005.04.005

Biology of Blood and Marrow Transplantation
Volume 11, Issue 8 , Pages 593-599 , August 2005

Article Tools

* Image Usage & Resolution